British drugmaker AstraZeneca Plc said on Thursday its vaccine was 76% effective in preventing symptomatic COVID-19 and that it has submitted the results to the US Data and Safety Monitoring Board.
The development comes after health officials publicly criticized the drugmaker for using "outdated information" to show how well the immunization worked.
AstraZeneca COVID-19 vaccine 76% effective in updated US trial results
By REUTERS
04/19/2024 09:51 AM
By REUTERS
04/19/2024 09:34 AM
By REUTERS
04/19/2024 09:28 AM
By REUTERS
04/19/2024 09:10 AM
By REUTERS
04/19/2024 09:01 AM
By REUTERS
04/19/2024 08:41 AM
By REUTERS
04/19/2024 06:37 AM
By REUTERS
04/19/2024 03:29 AM
By REUTERS
04/19/2024 02:03 AM
By REUTERS
04/19/2024 01:07 AM